Study of SYN818 With Olaparib for the Treatment of Locally Advanced or Metastatic Solid Tumors
Status:
RECRUITING
Trial end date:
2029-02-25
Target enrollment:
Participant gender:
Summary
This interventional study will evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics and preliminary efficacy of SYN818 with Olaparib in adult patients with locally advanced or metastatic solid tumors